Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics

The purpose of this Notice is to announce that the National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of Biomedical Imaging and Bioengineering (NIBIB) and the National Cancer Institute (NCI) are encouraging new applications to support translational research and development of rapid Point-of-Care diagnostics that will diagnose active viremic HCV infections.

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

This Notice of Funding Opportunity (NOFO), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID.

Allyson Mateja, M.S.P.H.

Viral Shedding Ebbs Over Time with HSV-1 Genital Infections

UC Research Could Change Vaccine Practices

ABL Awarded NIH Contract for Continued Support of HIV Vaccine Development

New Study Takes Major Step in Pursuit of HIV Cure

New Islet Transplant Method Leads to Insulin Independence

Diversifying the Next Generation of TB Vaccines

Learning from the Past to Improve SARS-CoV-2 Variant Discovery

Subscribe to